Commonwealth Coat of Arms of Australia

 

Veterans’ Affairs Pharmaceutical Benefits Schemes (Continued Dispensing—Emergency Measure) Amendment Determination 2025 (No. 2)

I, Andrew Kefford, a delegate of the Minister for Veterans’ Affairs, approve the following instrument for the purposes of:

  1.     subsection 286(6) of the Military Rehabilitation and Compensation Act 2004 as a determination by the Military Rehabilitation and Compensation Commission; and
  2.     subsection 91(5) of the Veterans’ Entitlements Act 1986 as a determination by the Repatriation Commission.

Dated  4 June 2025

Andrew Kefford PSM

Deputy Secretary, Policy & Programs

Department of Veterans’ Affairs


The Military Rehabilitation and Compensation Commission, under subsection 286(5) of the Military Rehabilitation and Compensation Act 2004, amends the MRCA Pharmaceutical Benefits Scheme by this determination.

Dated   3 June 2025

The Seal of the

Military Rehabilitation and

Compensation Commission

was affixed to this instrument

in the presence of:

Alison Frame

Mark Brewer

 

AM CSC and Bar

President

Repatriation Commission

Deputy President

Repatriation Commission

Gwen Cherne

Kahlil Fegan

 

DSC AM

Member

Member

 

Rear Admiral Letitia van Stralen

Michael Duke

AM CSC RAN

 

Member

Member

 


 

The Repatriation Commission, under subsection 91(4) of the Veterans’ Entitlements Act 1986, amends the Repatriation Pharmaceutical Benefits Scheme by this determination.

Dated  3 June 2025

The Seal of the

Repatriation Commission

was affixed to this instrument

in the presence of:

Alison Frame

Mark Brewer

 

AM CSC and Bar

President

 

Deputy President

 

Gwen Cherne

Kahlil Fegan

 

DSC AM

Veteran Family Advocate Commissioner

Commissioner

 

 

 

 

1  Name...................................................2

2  Commencement............................................2

3  Authority................................................2

4  Schedules................................................2

Schedule 1—Amendments 3

MRCA Pharmaceutical Benefits Scheme 3

Repatriation Pharmaceutical Benefits Scheme 3

 

 

  This instrument is the Veterans’ Affairs Pharmaceutical Benefits Schemes (Continued Dispensing—Emergency Measure) Amendment Determination 2025 (No.2).

  This instrument is taken to have commenced at the same time as the commencement of Part 1 of the National Health (Continued Dispensing – Emergency Measure) Determination 2025 (No.2).

  This instrument is made under:

  1.     subsection 286(5) of the Military Rehabilitation and Compensation Act 2004; and
  2.    subsection 91(4) of the Veteran’s Entitlements Act 1986.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

(section 4)

1  Paragraph 16A(1A)(b)

omit

National Health (Continued Dispensing – Emergency Measure) Determination 2025

substitute

National Health (Continued Dispensing – Emergency Measure) Determination 2025 (No.2)

2  Paragraph 16A(1A)(b)

omit

National Health (Continued Dispensing – Emergency Measure) Determination 2025

substitute

National Health (Continued Dispensing – Emergency Measure) Determination 2025 (No.2)